Amir Cohen Sells 4,655 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 4,655 shares of Strata Critical Medical stock in a transaction on Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the sale, the chief accounting officer owned 146,608 shares of the company’s stock, valued at $860,588.96. This represents a 3.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25.
• On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00.

Strata Critical Medical Stock Up 0.2%

NASDAQ:SRTA opened at $5.49 on Friday. The company has a fifty day moving average of $5.19. The company has a market cap of $475.03 million, a price-to-earnings ratio of -68.63 and a beta of 2.20. Strata Critical Medical has a twelve month low of $3.57 and a twelve month high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.07. The company had revenue of $67.38 million during the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. Equities research analysts anticipate that Strata Critical Medical will post -0.14 EPS for the current fiscal year.

Institutional Trading of Strata Critical Medical

Several hedge funds have recently bought and sold shares of SRTA. Seelaus Asset Management LLC grew its position in Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after purchasing an additional 6,000 shares during the period. Granite Investment Partners LLC grew its position in Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after purchasing an additional 7,911 shares during the period. Principal Financial Group Inc. acquired a new stake in Strata Critical Medical in the 1st quarter valued at $537,000. Dimensional Fund Advisors LP grew its position in Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after purchasing an additional 172,154 shares during the period. Finally, Quantinno Capital Management LP grew its position in Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after purchasing an additional 71,155 shares during the period. Institutional investors and hedge funds own 47.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on SRTA. Craig Hallum began coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective for the company. B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price target for the company. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Finally, Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.